| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/13/2011 | EP1737467B1 Composition for the treatment of skin conditions |
| 07/13/2011 | EP1620113B1 Topical formulation of ivermectin for the treatment of dermatological conditions |
| 07/13/2011 | EP1486491B1 Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 07/13/2011 | EP1367886B1 Scce transgenic mice and their use as models of human disease |
| 07/13/2011 | EP1265878B1 A process for the preparation of epothilone analogs and intermediates |
| 07/13/2011 | EP1181001B1 Sunscreen composition containing sol-gel microcapsules |
| 07/13/2011 | CN1353609B Amide substituted imidazoquinolines |
| 07/13/2011 | CN1175976B Arachidonic acid and method for production and use thereof |
| 07/13/2011 | CN102123763A Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| 07/13/2011 | CN102123735A Agent for induction/maintenance of remission |
| 07/13/2011 | CN102123705A Dermatological pharmaceutical composition for the treatment of skin inflammation diseases, such as dermatitis, atopic dermatitis, vitiligo, alopecia areata, acne, psoriasis, pruritus or combinations of same |
| 07/13/2011 | CN102123704A Organic compounds for wound healing |
| 07/13/2011 | CN102120773A Dual specificity antibodies and methods of making and using |
| 07/13/2011 | CN102120033A Collagen sustained-release carrier material for promoting repair of various traumas in oral and maxillofacial regions and method for preparing same |
| 07/13/2011 | CN102120031A Pharmaceutical compositions and methods for accelerating wound healing |
| 07/13/2011 | CN102120018A Medicament for treating phlegm stasis acnes |
| 07/13/2011 | CN102120002A Traditional Chinese medicament for treating scalds and preparation method thereof |
| 07/13/2011 | CN102119991A Composition with effects on blackening and increasing hair |
| 07/13/2011 | CN102119976A External preparation for treating acute inflammatory exudative skin diseases |
| 07/13/2011 | CN102119975A Chinese herbal medicine ointment for treating ulcer, bedsore, vasculitic dermatosis and infectious dermatosis |
| 07/13/2011 | CN102119973A Quality control method for gardenia percolate |
| 07/13/2011 | CN102119969A Medicine for treating eczema and preparation method thereof |
| 07/13/2011 | CN102119938A Folk Chinese herb medicine fruiting eight trigram-shaped maple root wine |
| 07/13/2011 | CN102119916A Liquid oxygen in-situ forming gel and preparation method and application thereof |
| 07/13/2011 | CN101690739B Preparation method of dogbane leaf extractive |
| 07/13/2011 | CN101664488B Traditional Chinese medicine for treating infant eczema |
| 07/13/2011 | CN101632775B Externally-applied traditional Chinese medicine ointment |
| 07/13/2011 | CN101306126B Quality control method of compound south isatis root granules |
| 07/12/2011 | US7977350 CCR1 antagonists and methods of use therefor |
| 07/12/2011 | US7977316 Prevention and treatment of amyloidogenic diseases |
| 07/12/2011 | US7976881 Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them |
| 07/12/2011 | US7976836 Treatment of stroke using placental stem cells |
| 07/12/2011 | CA2481767C Severe sepsis preventive therapeutic agent |
| 07/12/2011 | CA2463505C Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin d3 |
| 07/12/2011 | CA2458455C Pharmaceutical compositions comprising colloidal silicon dioxide |
| 07/12/2011 | CA2449150C Tricyclic compounds useful as angiotensin ii agonists |
| 07/12/2011 | CA2435611C Alpha-amino-n-hydroxy-acetamide derivatives |
| 07/12/2011 | CA2406570C Dermal compositions containing coenzyme q as the active ingredient |
| 07/12/2011 | CA2393312C Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 07/12/2011 | CA2373972C Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 07/12/2011 | CA2346384C Method for prevention and/or cosmetic treatment of skin striae and use in dermatology |
| 07/12/2011 | CA2341336C Elongase genes and uses thereof |
| 07/07/2011 | WO2011081861A2 Hair growth and / or regrowth compositions |
| 07/07/2011 | WO2011081716A1 Topical acyl glutathione formulations |
| 07/07/2011 | WO2011081715A1 Topical acyl glutathione psoriasis formulations |
| 07/07/2011 | WO2011081173A1 Tetracyclic compound |
| 07/07/2011 | WO2011080887A1 Sebum secretion-blocking composition, and food or beverage containing same |
| 07/07/2011 | WO2011080722A2 Use of skin permeation and retention enhancer compound in cosmetic and pharmaceutical compositions and cosmetic and pharmaceutical products containing said compound |
| 07/07/2011 | WO2011080220A1 An agent for stimulating the expression of loxl |
| 07/07/2011 | WO2011058423A3 Identification and characterization of natural chemical entities by liquid chromatography and mass spectrometry lc-ms/ms and uses thereof |
| 07/07/2011 | WO2011021892A3 Composition for skin improvement comprising hexamidines and retinoids |
| 07/07/2011 | WO2010057275A8 Cyclic peptides and uses thereof |
| 07/07/2011 | US20110166222 Vitamin c composition for use in the prevention and treatment of stretch marks, radiation dermatitis, and other skin conditions and methods of using the same |
| 07/07/2011 | US20110166219 Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin |
| 07/07/2011 | US20110166178 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase |
| 07/07/2011 | US20110166169 Novel hsp90 inhibitory carbazole derivatives, compositions containing same and use thereof |
| 07/07/2011 | US20110166159 Compounds that modulate intracellular calcium |
| 07/07/2011 | US20110166145 Stabilization of hypoxia inducible factor (HIF) alpha |
| 07/07/2011 | US20110166140 Novel sulphonylpyrroles |
| 07/07/2011 | US20110166133 Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
| 07/07/2011 | US20110166125 Substituted amides, manufacturing and use thereof as medicaments |
| 07/07/2011 | US20110166113 Method for treating the hyperpigmentation of pathological scars |
| 07/07/2011 | US20110166103 Boron-containing small molecules |
| 07/07/2011 | US20110166102 Novel 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
| 07/07/2011 | US20110166093 Use of adenosine receptor agonists in therapy |
| 07/07/2011 | US20110166076 Antigen-binding proteins that inhibit superantigens for the treatment of skin diseases |
| 07/07/2011 | US20110166067 Methods for inhibition of scarring |
| 07/07/2011 | US20110165276 Composition for burn treatment |
| 07/07/2011 | US20110165260 Allantoin-containing skin cream |
| 07/07/2011 | US20110165244 Bioresponsive polymer formulations for delivery of bioactive agents |
| 07/07/2011 | US20110165229 Compositions and Methods for Treatment |
| 07/07/2011 | US20110165228 Compositions and Methods for Treatment |
| 07/07/2011 | US20110165221 Wound care |
| 07/07/2011 | US20110165211 Carbon dioxide external preparation, and material for formation of carbon dioxide external preparation |
| 07/07/2011 | US20110165205 Nanovector with positive charge substantive for hair and skin |
| 07/07/2011 | US20110165203 A topical composition comprising the isolated non-polar lipid fraction of lanolin4 |
| 07/07/2011 | US20110165168 Cidea modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 07/07/2011 | US20110165143 Modulation of caspases and therapeutical applications |
| 07/07/2011 | US20110165136 Novel Herbal Composition for Treatment of Psoriasis and Other Skin Disorders |
| 07/07/2011 | US20110165130 Methods for Preparing Human Skin Substitutes from Human Pluripotent Stem Cells |
| 07/07/2011 | US20110165126 Enhanced Submucosal Tissue Graft Constructs |
| 07/07/2011 | US20110165114 Drug delivery composition |
| 07/07/2011 | US20110165100 Compositions comprising avermectin/azelaic acid compounds useful for treating, e.g., rosacea |
| 07/07/2011 | US20110165098 Methods to prevent cytotoxicity using n-acetyl-cysteine |
| 07/07/2011 | US20110165097 Compositions for percutaneous administration |
| 07/07/2011 | US20110165096 Ficus Extracts Having Angiogenesis Ihibiting Activity And Methods Of Isolating And using The Same |
| 07/07/2011 | US20110165095 Composition and method for the inhibition of postoperative adhesions severity |
| 07/07/2011 | US20110165092 Cosmetic and/or dermatological composition |
| 07/07/2011 | US20110165066 Interleukin-13 binding proteins |
| 07/07/2011 | US20110165064 Methods and compositions related to clot-binding compounds |
| 07/07/2011 | US20110165063 Il-1 binding proteins |
| 07/07/2011 | CA2785633A1 Topical acyl glutathione formulations |
| 07/07/2011 | CA2785599A1 Purified bowman-birk protease inhibitor proteins isolated from a soy processing stream |
| 07/07/2011 | CA2784842A1 Dibenzoyl peroxide derivatives, preparation method thereof and cosmetic or dermatological compositions containing same |
| 07/07/2011 | CA2782980A1 Hair growth and/or regrowth compositions |
| 07/06/2011 | EP2341143A1 OX2 receptor homolog |
| 07/06/2011 | EP2341068A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 07/06/2011 | EP2341045A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid (acyloxy)alkyl or ((alkoxycarbonyl)oxy)alkyl ester as SPLA2 inhibitor |
| 07/06/2011 | EP2340849A1 Anti-NGF antibodies for the treatment of various disorders |
| 07/06/2011 | EP2340840A1 Pulse dose Vitamin D drug for the treatment of hyperproliferative skin diseases |